Empowered Funds
MAIA icon

Empowered Funds’s MAIA Biotechnology MAIA Stock Holding History

Empowered Funds’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$88.2K Buy
+74,757
New +$101K ﹤0.01% 2429

Other funds holding MAIA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Centric Wealth Management
Centric Wealth Management Chicago, Illinois $657M AUM 18.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bleichroeder LP
Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Bleakley Financial Group
Bleakley Financial Group Fairfield, New Jersey $8.8B AUM 22.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Empowered Funds's MAIA Position: Q3 2026 in Review

Empowered Funds opened a new position in MAIA Biotechnology (MAIA) in Q3 2026: 74,757 shares worth $88.2K. The stake represents ﹤0.01% of the portfolio and ranks #2429 among its holdings.

31 funds tracked by Wall St. Rank hold MAIA as of Q3 2026.

  • Empowered Funds held 74,757 shares of MAIA Biotechnology worth $88.2K as of Q3 2026.
  • MAIA Biotechnology was a new Empowered Funds position in Q3 2026.
  • MAIA Biotechnology made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2429 holding.
  • 31 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.